NCT03999281

Clinical Trial to Examine Effectiveness of a Human Allograft for Treatment of DFU and VLU

Retrospective Clinical Trial Study of 188 Consecutive Patients to Examine the Effectiveness of a Biological Active Cryopreserved Human Skin Allograft on the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 188 (actual)
• Sponsor: Solsys Medical LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

Retrospective clinical study of 188 patients to examine effectiveness of human cryopreserved allograft in the treatment of diabetic foot ulcers and venous leg ulcers

Detailed description

Retrospective Observational study of 188 consecutive patients to examine the efficacy of biologically active cryopreserved human skin allograft (Theraskin) on the treatment of diabetic foot ulcers and venous leg ulcers

Conditions

• Determine Effectiveness of Theraskin in the Treatment of DFU and VLU

Interventions

Type	Name	Description
OTHER	Human Allograft (Theraskin)	Biologically active cryopreserved human skin allograft (Theraskin) was used on both cohorts, both diabetic foot ulcer and venous leg ulcer.

Timeline

• Start date: 2003-03-20
• Primary completion: 2009-09-20
• Completion: 2009-09-20
• First posted: 2019-06-26
• Last updated: 2019-06-28

Locations

1 site across 1 country: United States